跳至主要内容
临床试验/CTRI/2012/06/002732
CTRI/2012/06/002732已完成1/2 期

A Prospective, Multicentric, Open Label, Bio Interventional, Phase I, Phase II Pilot Study to Evaluate the Safety and Efficacy of Autologous Human Platelet Lysate (HPL) for Treatment of Acne Scarring

Kasiak Research Pvt Ltd2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年5月21日最近更新:

试验速览

阶段
1/2 期
状态
已完成
入组人数
20
试验地点
2
主要终点
•Changes in the Global Acne scarring classification scores from screening to end of the study.

研究概览

简要总结

This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Acne Scarring. The study is being conducted at 2 centers in India. The primary endpoint is change in the Global Acne scarring classification scores from screening to end of the study. The secondary endpoints are Photographic Assessment,  Physicians assessment score and Patients self assessment score.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Subjects (male and female), aged 18 to 40 years (both inclusive).
  • Subject willing to refrain from any other treatment of Acne Scarring during entire study duration.
  • Non-pregnant, non-lactating females who agree to use adequate and acceptable methods of contraception from screening and throughout the course of the study.
  • Subjects who are willing to give informed consent and adhere to the study protocol.

排除标准

  • Subjects with active infection or active acne.
  • Subjects receiving treatment: NSAIDs treatment within the last 7 days prior to the study.
  • Subjects with history of connective tissue disease.
  • Subjects with known bleeding disorders such as platelet dysfunction syndrome, thrombocytopenia, hypofibrinogenemia.
  • Subjects who have received prior chemotherapy and radiotherapy
  • Subjects unwilling to or unable to comply with the study protocol.
  • Subjects taking concomitant therapy that might interfere with the study results in the investigator’s opinion or participating in another trial in the past 30days.

结局指标

主要结局

•Changes in the Global Acne scarring classification scores from screening to end of the study.

时间窗: End of study - 4 Months

次要结局

  • • Photographic Assessment(• Physician’s assessment scores for acne scarring.)

研究者

申办方类型
Other [Biotechnology company]

研究点 (2)

Loading locations...

相似试验